In the first instalment of this two-part episode with Donald Ingber, Founding Director of the Wyss Institute (MA, USA), we discuss his invention of organ-on-a-chip technology, how he is utilizing them in the fight against COVID-19 and the Wyss Institute's response to the pandemic. Donald touches on the performance of the much-discussed chloroquine in his lung-on-a-chip models. We also discuss the pros and cons of organ-on-a-chip technology verses organoids, exploring their use in combination, before Donald examines the possible replacement of animal models with organ-on-a-chip technology.*The Talking Techniques podcast is hosted and produced by Tristan Free for BioTechniques. We would love to here more from our listeners about your opinions on the podcast, what you would like to hear more of and what you think we could do better!Please get in contact on any of the platforms below.Twitter: @TristanFreefsgEmail: [email protected] Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.